148 related articles for article (PubMed ID: 32324838)
1. Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018.
Medhin LB; Achila OO; Syum BE; Gebremichael KH; Said SM; Lobeck H; Ghidei YT
PLoS One; 2020; 15(4):e0232091. PubMed ID: 32324838
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
Medhin LB; Tekle LA; Achila OO; Said S
Sci Rep; 2020 Jun; 10(1):9099. PubMed ID: 32499531
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Incidence of colorectal cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
Medhin LB; Achila OO; Abrham AT; Efrem B; Hailu K; Abraha DM; Gilazghi L; Meresie A; Said SM
PLoS One; 2019; 14(11):e0224045. PubMed ID: 31721763
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
Al Shareef Z; Al-Shahrabi R; Saheb Sharif-Askari F; AlDhmanie A; Alshamsi Y; Zarooni AA; Mahmoud RA; Soliman SSM; Halwani R; Bendardaf R
Prostate; 2024 Feb; 84(2):185-192. PubMed ID: 37969038
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008.
Alghamidi IG; Hussain II; Alghamdi MS; El-Sheemy MA
Hematol Oncol Stem Cell Ther; 2014 Mar; 7(1):18-26. PubMed ID: 24239850
[TBL] [Abstract][Full Text] [Related]
9. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer age-standardised incidence increase between 2006 and 2016 in Gauteng Province, South Africa: A laboratory data-based analysis.
Cassim N; Ahmad A; Wadee R; Rebbeck TR; Glencross DK; George JA
S Afr Med J; 2020 Dec; 111(1):26-32. PubMed ID: 33404002
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan.
Wu CC; Lin CH; Chiang HS; Tang MJ
Int J Equity Health; 2018 Jun; 17(1):79. PubMed ID: 29903010
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological trends in prostate cancer over the last years].
Luján Galán M; Páez Borda A; Chiva Robles V; Santonja Garriga C; Romero Cajigal I; Berenguer Sánchez A
Arch Esp Urol; 2004 Oct; 57(8):817-25. PubMed ID: 15560270
[TBL] [Abstract][Full Text] [Related]
14. Estimation of time trends of incidence of prostate cancer--an Indian scenario.
Lalitha K; Suman G; Pruthvish S; Mathew A; Murthy NS
Asian Pac J Cancer Prev; 2012; 13(12):6245-50. PubMed ID: 23464439
[TBL] [Abstract][Full Text] [Related]
15. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis.
Adeloye D; David RA; Aderemi AV; Iseolorunkanmi A; Oyedokun A; Iweala EE; Omoregbe N; Ayo CK
PLoS One; 2016; 11(4):e0153496. PubMed ID: 27073921
[TBL] [Abstract][Full Text] [Related]
16. Significantly reduced incidence and improved survival from prostate cancer over 25 years.
Serdà-Ferrer BC; Sanvisens A; Fuentes-Raspall R; Puigdemont M; Farré X; Vidal-Vila A; Rispau-Pagès M; Baltasar-Bagué A; Marcos-Gragera R
BMC Public Health; 2023 Dec; 23(1):2552. PubMed ID: 38129873
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
20. Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Testing.
Kappen S; de Bock GH; Sirri E; Vohmann C; Kieschke J; Winter A
Front Oncol; 2021; 11():681006. PubMed ID: 34123851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
